Expert evaluation of priority areas for implementation of medical and pharmaceutical technologies in Ukraine
DOI:
https://doi.org/10.14739/2310-1210.2025.1.315813Keywords:
healthcare system, public administration, health technology assessment, health technology, pharmaceutical technology, questionnaire, healthcare professionals, expert evaluationAbstract
Aim. To analyze survey results of healthcare (НС) professionals on the status, problems and prospects of implementing medical and pharmaceutical technologies in Ukraine and their proper appraisal.
Materials and methods. A comprehensive sociological study was conducted via an online survey using Google forms (September – December 2023). Two questionnaires were developed and tested for this purpose, one for public administration professionals and another for health technology assessment (HTA) specialists. Respondents were selected by purposive sampling based on their managerial experience, education, and professional qualifications. In total, 164 НС system managers of different levels and 77 HTA specialists were enrolled in the study. The methods of system analysis, mathematical and statistical, generalization, comparison, descriptive, and graphical were used to process and interpret the results.
Results. Based on current scientific concepts and regulatory requirements, medical and pharmaceutical technologies include various methods, procedures, systems or tools applied in the field of HC for treatment, diagnosis, prevention, medical rehabilitation and palliative care. The WHO also defines HC technologies as public health measures and interventions at the population level (such as vaccination, screening), targeted programs, and treatment standards (protocols, guidelines). The modern НТА methodology as a scientific and practical concept is now developing quite dynamically in the world and has specific features of implementation in different countries.
Conclusions. Since НТА is an internationally recognized tool to support effective management decision-making, a comparison between НТА specialist and НС manager opinions on the status, problems and prospects of НТА implementation in Ukraine has been important in the study. The respondents have reported the formation of a professional environment, improvement of legislation, international cooperation, infrastructure development and capacity building as the most probable scenario for the НТА implementation in Ukraine.
References
WHO Country Cooperation Strategy, Ukraine 2024-2030 [Internet]. Copenhagen: WHO Regional Office for Europe; 2024 [cited 2024 Nov 2]. 28 р. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2024-9329-49101-73236
Resource Guide on the Use of Health Technology Assessment in Health Benefit Package Design Processes [Internet]. [cited 2024 Oct 28]. Available from: https://www.who.int/teams/health-financing-and-economics/economic-analysis/health-technology-assessment-and-benefit-package-design/resource-guide-for-the-use-of-hta-and-hbp-design-processes
WHO Health Technology Assessment Survey 2020/21. Main findings. [Internet]. [cited 2024 Oct 25]. Available from: https://www.who.int/data/stories/health-technology-assessment-a-visual-summary
From value for money to value-based health services: a twenty-first century shift. WHO policy brief. World Health Organization 2021. 9 p.
Health Technology Assessment and Health Benefit Package Survey 2020/2021. [Internet]. [cited 2024 Oct 25]. Available from: https://www.who.int/teams/health-financing-and-economics/economic-analysis/health-technology-assessment-and-benefit-package-design/survey-homepage
Tutuk V, Nazarkina V, Babenko M, Nemchenko A, Zhakipbekov K. Assessment of medical technologies in the formation of government programs to assist patients with rare metabolic diseases. ScienceRise: Pharmaceutical Science. 2023;(5):99-108. doi: https://doi.org/10.15587/2519-4852.2023.290218
Nemchenko A, Kurylenko Y, Nazarkina V, Lyadenko A. Analysis opinions pharmacists on the implementation of government programs to increase availability of medicines in Ukraine and the world. PharmacologyOnline. 2021;2:1356-64.
Babenko MM. Expert evaluation of the problems of public administration in the context of reforming the health care sector. Pharmaceutical Review. 2024;(2):85-92. doi: https://doi.org/10.11603/2312-0967.2024.2.14637
Bertram M, Dhaene G, Tan-Torres Edejer T, editors. Institutionalizing health technology assessment mechanisms: a how to guide [Internet]. Geneva: World Health Organization; 2021 [cited 2024 Nov 2]. 66 р.
Castro HE, Kumar R, Suharlim C, Guzman J, Gilmartin C, Amaris AM, et al. A Roadmap for Systematic Priority Setting and Health Technology Assessment (HTA) [Internet]. Arlington, VA: USAID/MSH. 2020. [cited 2024 Nov 2]. 115 р. Available from: https://msh.org/wp-content/uploads/2022/01/HTA_Roadmap_2020-1-1.pdf
Kristensen FB, Husereau D, Huic M, Drummond M, Berger ML, Bond K et al. Identifying the need for good practices in health technology assessment: summary of the ISPOR HTA council working group report on good practices in HTA. Value in Health. 2019;22(1):13-20. doi: https://doi.org/10.1016/j.jval.2018.08.010
Drummond MF, Augustovski F, Bhattacharyya D, Campbell J, Chaiyakunapruk N, Chen Y, et al. Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report. Value Health. 2022;25(8):1257-67. doi: https://doi.org/10.1016/j.jval.2022.02.006
Teerawattananon Y, Painter C, Dabak S, Ottersen T, Gopinathan U, Chola L, et al. Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making. Cost Eff Resour Alloc. 2021;19:62. https://doi.org/10.1186/s12962-021-00308-1
Csanádi M, Inotai A, Oleshchuk O, Lebega O, Brodovskaya A, Piniazhko О, et al. Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives. Int J Technol Assess Health Care. 2019;35(5):393-400. doi: https://doi.org/10.1017/S0266462319000679
Zou PX, Xu X. Research Methodology and Strategy. Theory and Practice. Wiley & Sons. 2023;256 р. doi: https://doi.org/10.1002/9781394190256
Samborskyi OS, Slobodianiuk MM, Shuvanova OV. Obgruntuvannia vyboru metodu formuvannia vybirky u doslidzhenniakh farmatsevtychnoho rynku [Justification of the choice of sampling method in pharmaceutical market research]. Kharkiv: NFaU; 2017. Ukrainian. Available from: http://dspace.nuph.edu.ua/handle/123456789/14232
Kotvitska AA, Nemchenko AS, Nazarkina VN. The relevance of training specialists in the Health Technology Assessment in the world and Ukraine. Pharmacia. 2020;67(4):295-301. doi: https://doi.org/10.3897/pharmacia.67.e54777
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
